Security Snapshot

NEOGENOMICS INC - Common Stock, $0.01 par value (NEO) Institutional Ownership

CUSIP: 64049M209

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

261

Shares (Excl. Options)

144,847,453

Price

$14.59

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+10,884,754
Value change
+$194,846,384
Number of holders
261
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
128,549,415
SEC-reported price per share
$15.88
Insider filing price
$15.88
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • NEO - NEOGENOMICS INC - Common Stock, $0.01 par value is tracked under CUSIP 64049M209.
  • 261 institutions reported positions in Q2 2026.
  • 10 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 249 to 261 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $993,412,648 to $2,110,561,111.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 261 institutions filings for Q2 2026.

Open SEC evidence

Security key

64049M209

Latest holder period

Q2 2026

13F holders

261

13D/G owners

10

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
10
Security
NEO
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 16% +6.7% $297,028,049 +$21,831,849 20,358,331 +7.9% BlackRock, Inc. 30 Jun 2026
First Light Asset Management, LLC 8.4% -22% $151,817,758 -$47,040,341 10,759,586 -24% Mathew P. Arens 30 Jun 2026
FIRST TRUST PORTFOLIOS LP 7.8% $147,552,478 10,113,261 First Trust Portfolios L.P. 30 Jun 2026
Greenhouse Funds LLLP 7.1% +22% $75,754,723 +$14,670,694 9,215,903 +24% Greenhouse Funds LLLP 31 Mar 2026
VANGUARD PORTFOLIO MANAGEMENT LLC 5.9% $56,969,231 7,677,794 Vanguard Portfolio Management 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.1% $49,048,218 6,610,272 Vanguard Capital Management 31 Mar 2026
JANUS HENDERSON GROUP PLC 4.8% $63,315,197 6,165,063 JANUS HENDERSON GROUP PLC 31 Dec 2024
INTEGRATED CORE STRATEGIES (US) LLC 2.8% -52% $26,073,366 -$24,761,251 3,566,808 -49% Millennium Management LLC 30 Jun 2025
T. Rowe Price Investment Management, Inc. 2.6% $34,067,326 3,317,169 T. Rowe Price Investment Management, Inc. 31 Mar 2025
MILLENNIUM MANAGEMENT LLC 1.7% -66% $18,271,063 -$35,022,716 2,222,757 -66% Millennium Management LLC 31 Mar 2026

As of 30 Jun 2026, 261 institutional investors reported holding 144,847,453 shares of NEOGENOMICS INC - Common Stock, $0.01 par value (NEO). This represents 113% of the company’s total 128,549,415 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
93%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 16% 20,868,362 +4.6% 0% $304,469,400
First Light Asset Management, LLC 9.6% 12,279,523 +26% 11% $179,158,241
FIRST TRUST ADVISORS LP 7.9% 10,113,261 +64% 0.09% $147,552,477
Greenhouse Funds LLLP 6.7% 8,574,210 -5.8% 6.6% $125,097,724
VANGUARD PORTFOLIO MANAGEMENT LLC 6.3% 8,061,362 +5.8% 0.01% $117,615,272
VANGUARD CAPITAL MANAGEMENT LLC 4.5% 5,763,017 +1.9% 0% $84,082,418
STATE STREET CORP 4.2% 5,363,784 +4.8% 0% $78,257,609
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 3.9% 5,037,787 +46% 0.11% $73,501,000
BRAIDWELL LP 3.8% 4,918,202 -12% 2.7% $71,756,567
SCHRODER INVESTMENT MANAGEMENT GROUP 3.4% 4,342,883 +22% 0.04% $61,886,083
GEODE CAPITAL MANAGEMENT, LLC 2.7% 3,428,123 +6.1% 0% $50,025,999
MILLENNIUM MANAGEMENT LLC 2.4% 3,079,542 +39% 0.03% $44,930,518
LOOMIS SAYLES & CO L P 2% 2,537,717 +30% 0.05% $37,025,291
Driehaus Capital Management LLC 2% 2,508,845 +46% 0.21% $36,604,049
BANK OF AMERICA CORP /DE/ 1.9% 2,436,329 -20% 0% $35,546,038
DIMENSIONAL FUND ADVISORS LP 1.9% 2,399,411 -10% 0.01% $35,003,708
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.9% 2,391,784 0.02% $34,896,129
AMERICAN CAPITAL MANAGEMENT INC 1.7% 2,237,707 -0.59% 1.5% $32,648,145
D. E. Shaw & Co., Inc. 1.7% 2,194,758 -47% 0.02% $32,021,519
SAMLYN CAPITAL, LLC 1.7% 2,131,337 -17% 0.52% $31,096,207
GW&K Investment Management, LLC 1.7% 2,129,421 -2.8% 0.24% $31,068,000
Aberdeen Group plc 1.5% 1,931,525 -4.7% 0.04% $28,180,950
MORGAN STANLEY 1.5% 1,898,128 -12% 0% $27,693,709
GOLDMAN SACHS GROUP INC 1.2% 1,566,760 +56% 0% $22,859,028
NORTHERN TRUST CORP 1.2% 1,539,181 -2.6% 0% $22,456,651

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 144,847,453 $2,110,561,111 +$194,846,384 $14.59 261
2026 Q1 134,004,955 $993,412,648 +$6,780,955 $7.42 249
2025 Q4 130,819,553 $1,540,501,664 +$16,782,695 $11.76 256
2025 Q3 128,856,828 $995,144,233 +$13,772,890 $7.72 251
2025 Q2 127,102,311 $928,960,411 -$11,861,045 $7.31 269
2025 Q1 126,074,888 $1,197,235,152 +$20,732,141 $9.49 248
2024 Q4 122,630,250 $2,020,773,423 -$19,292,481 $16.48 247
2024 Q3 123,905,582 $1,824,489,746 -$30,173,686 $14.75 265
2024 Q2 125,764,461 $1,744,349,407 -$25,594,791 $13.87 253
2024 Q1 128,566,414 $2,021,077,127 +$40,223,752 $15.72 260
2023 Q4 125,750,435 $2,034,740,144 +$91,247,148 $16.18 282
2023 Q3 120,319,823 $1,480,068,392 +$31,109,122 $12.30 278
2023 Q2 117,354,505 $1,887,976,537 +$17,892,372 $16.07 261
2023 Q1 116,149,860 $2,022,087,874 +$68,408,756 $17.41 250
2022 Q4 112,517,309 $1,039,664,895 +$6,813,825 $9.24 235
2022 Q3 112,517,984 $968,760,212 -$61,344,388 $8.61 236
2022 Q2 117,343,229 $956,378,739 +$558,727 $8.15 222
2022 Q1 110,849,435 $1,347,014,006 -$178,663,861 $12.15 262
2021 Q4 117,712,710 $4,016,513,724 +$21,819,286 $34.12 302
2021 Q3 115,633,668 $5,577,437,288 +$212,796,154 $48.24 318
2021 Q2 111,349,475 $5,028,565,162 +$185,109,189 $45.17 308
2021 Q1 108,007,395 $5,210,316,095 +$250,630,845 $48.23 326
2020 Q4 103,918,826 $5,595,174,116 +$117,101,727 $53.84 336
2020 Q3 101,942,927 $3,761,276,674 -$19,415,173 $36.89 287
2020 Q2 102,197,271 $3,169,534,118 +$257,605,485 $30.98 278
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .